From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Respiratory Infections>
  4. Archives

Respiratory Infections: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 301-325 of 423 are shown

New Bronchiolitis Guidelines

Evidence-based recommendations for diagnosis and management of bronchiolitis

Early Switch to Oral Antibiotics in CAP

Outcomes in patients with severe community-acquired pneumonia were not adversely affected by an early switch from IV to oral antibiotics.

Poor Countries Expected to Bear Brunt of Influenza Pandemic

Of the 62 million excess deaths projected to occur in an influenza pandemic, 96% would be in the developing world.

Childcare Illness Rates: Who’s at Risk?

In childcare facilities, the youngest children and newcomers were at increased risk for respiratory infections.

VAP Outcome Not Affected by Diagnostic Techniques

Outcomes were comparable whether ventilator-associated pneumonia was diagnosed with nonquantitative endotracheal cultures or with quantitative bronchoalveolar-lavage cultures.

A New Rule for Predicting Severe CAP

Researchers propose a rule, based on eight clinical criteria, for identifying patients at risk for developing severe community-acquired pneumonia within 24 hours of hospital admission.

Infections Increase the Risk for MS Relapses

In this important study, immunologic and MRI data support the hypothesis that acute infections can trigger MS exacerbations.

A Report Card for the Worrisome 2004–2005 Flu Vaccine

Even in a year of antigenic drift, both forms of influenza vaccine performed reasonably well.

Yet Another Harmful Effect of Smoking

Smokers have an increased risk for infection with <$EMPH_O>M. pneumoniae.<$EMPH_C>

Appropriate Treatment of Bacteremic Nosocomial Pneumonia — Back to Surveillance Cultures?

Tracheal surveillance cultures provided significant benefit in detecting the pathogens responsible for bacteremic nosocomial pneumonia.

New Vaccines and Updates

Rotavirus vaccine, human papillomavirus vaccine, and varicella vaccine

What’s New with the Flu?

Updated recommendations for influenza vaccines need ongoing evaluation.

Updates on H5N1

Two new studies document the characteristics of human H5N1 influenza in Turkey and of three clusters in Indonesia.

Flu Vaccine and GBS: Two Studies, No Answer

Two observational studies published in a single paper yielded conflicting information about the association between Guillain-Barré syndrome and influenza vaccination.

Pneumococcal Conjugate Vaccine Effective in Various Dose Schedules

Even "underdosing" offers substantial protection.

Avian Flu: Deadly, and Difficult to Diagnose

. . . but still causing only scattered cases of human disease.

Active Pulmonary TB Diagnosed by ELISPOT of BAL Fluid

ELISPOT for interferon-{gamma} using cells in bronchoalveolar lavage fluid was sensitive and specific for diagnosing active pulmonary TB in patients with negative sputum acid-fast smears.

23-Valent Pneumococcal Vaccine Lowers Bacteremia Risk

. . .but offers little protection against nonbacteremic pneumonia.

A Sneeze May Launch a Thousand Staph

With a histamine challenge, <$EMPH_O>S. aureus<$EMPH_C> carriers spewed organisms into their surroundings.

Extensively Drug-Resistant TB: Bad News

XDR-TB progresses rapidly, spreads nosocomially, causes high mortality, and is more prevalent than previously recognized.

A Vaccine Effective Against the 1918 Flu Virus

An experimental DNA vaccine protected mice against the reconstructed 1918 H1N1 influenza virus.

Celiac Disease and TB Risk

Using data from Swedish national registers, researchers showed a strong association between celiac disease and TB, but the mechanism remains unclear.

Safety of Inactivated Flu Vaccine in Children

Investigators examining the safety of trivalent inactivated influenza vaccine found no increased risk for any serious condition in children 6 to 23 months old.

Vancomycin Levels and Mortality in MRSA Pneumonia

Higher vancomycin levels or AUC values did not affect outcomes in patients with MRSA pneumonia.

Is Influenza Vaccination Safe in Young Children?

A large population-based study of 6- to 23-month-old children found that it is.

Items 301-325 of 423 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.